I am not bullish on this stock, but I was thinking about that possible FDA violation. Somebody said that is where they might get dinged by the SEC because of their comments on the FDA approval or something.
I think they will probably walk on that one. Wasn't managment referring to their ingredients as being all FDA cleared? So the information was a bit convoluted in their 10K, but they will probably get off on that one.
Donovan...nope, they were referring to their products. Here is an exerpt from their original prospectus: "All three of these products have been through the research and development, pre-clinical study and clinical trial stages and have received FDA approval. They are either currently being marketed and commercialized or will enter the marketing and commercialization phase upon the consummation of this offering."
vaso management claimed fda approval for the product itself, also patents for the vale technology, but nobody knows if they exist, masiz said that there was institutional interest ti justify the split, probably just to hype the stock and its price, if you take the patents away, the stock price will deflate like the internet bubble, maybe some investors will start suing management for misleading statements, this won�t help the stock price either. the answer to the question when will vaso be a penny stock, is less than two weeks.